105 related articles for article (PubMed ID: 1629751)
1. The influence of serum proteins on biological activity of anticandidal peptides containing N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid.
Kasprzak L; Milewski S; Gumieniak J; Borowski E
J Chemother; 1992 Apr; 4(2):88-94. PubMed ID: 1629751
[TBL] [Abstract][Full Text] [Related]
2. [Synthesis and anti-Candida albicans properties of L-4-oxalysine-N3-4-methoxyfumaroyl-L-2,3-diaminopropanoic-containing peptide analogues].
Feng S; Xu X; Zhang H
Yao Xue Xue Bao; 1998 Jun; 33(6):429-35. PubMed ID: 12016912
[TBL] [Abstract][Full Text] [Related]
3. Anticandidal properties of N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid oligopeptides.
Andruszkiewicz R; Milewski S; Zieniawa T; Borowski E
J Med Chem; 1990 Jan; 33(1):132-5. PubMed ID: 2104933
[TBL] [Abstract][Full Text] [Related]
4. A diffusible analogue of N(3)-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid with antifungal activity.
Zgódka D; Milewski S; Borowski E
Microbiology (Reading); 2001 Jul; 147(Pt 7):1955-1959. PubMed ID: 11429472
[TBL] [Abstract][Full Text] [Related]
5. Antifungal activity of thionated analogues of Nva-FMDP and Lys-Nva-FMDP.
Nowak-Jary J; Andruszkiewicz R
Pol J Microbiol; 2009; 58(4):295-9. PubMed ID: 20380139
[TBL] [Abstract][Full Text] [Related]
6. Antifungal peptides with novel specific inhibitors of glucosamine 6-phosphate synthase.
Milewski S; Chmara H; Andruszkiewicz R; Borowski E; Zaremba M; Borowski J
Drugs Exp Clin Res; 1988; 14(7):461-5. PubMed ID: 3149235
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of anticandidal dipeptides containing inhibitors of glucosamine-6-phosphate synthase.
Milewski S; Andruszkiewicz R; Kasprzak L; Mazerski J; Mignini F; Borowski E
Antimicrob Agents Chemother; 1991 Jan; 35(1):36-43. PubMed ID: 1901701
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, anticandidal activity of N(3)-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic amide derivatives--novel inhibitors of glucosamine-6-phosphate synthase.
Pawlak D; Stolarska M; Wojciechowski M; Andruszkiewicz R
Eur J Med Chem; 2015 Jan; 90():577-82. PubMed ID: 25497131
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP.
Milewski S; Mignini F; Covelli I; Borowski E
J Med Vet Mycol; 1994; 32(1):1-11. PubMed ID: 8207618
[TBL] [Abstract][Full Text] [Related]
10. Amide and ester derivatives of N3-(4-methoxyfumaroyl)-(S)-2,3-diaminopropanoic acid: the selective inhibitor of glucosamine-6-phosphate synthase.
Zgódka D; Jedrzejczak R; Milewski S; Borowski E
Bioorg Med Chem; 2001 Apr; 9(4):931-8. PubMed ID: 11354676
[TBL] [Abstract][Full Text] [Related]
11. [Determination of degradation level of antifungal agent in mice serum by high performance liquid chromatography].
Tang Q; Feng S; Xu X; Huang J
Se Pu; 1997 Mar; 15(2):144-6. PubMed ID: 15739405
[TBL] [Abstract][Full Text] [Related]
12. Facilitated diffusion of glucosamine-6-phosphate synthase inhibitors enhances their antifungal activity.
Janiak A; Cybulska B; Szlinder-Richert J; Borowski E; Milewski S
Acta Biochim Pol; 2002; 49(1):77-86. PubMed ID: 12136959
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial action of dipeptides containing an inhibitor of glucosamine-6-phosphate isomerase.
Chmara H; Milewski S; Andruszkiewicz R; Mignini F; Borowski E
Microbiology (Reading); 1998 May; 144 ( Pt 5)():1349-1358. PubMed ID: 9660640
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological properties of N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid dipeptides, a novel group of antimicrobial agents.
Andruszkiewicz R; Chmara H; Milewski S; Borowski E
J Med Chem; 1987 Oct; 30(10):1715-9. PubMed ID: 3309312
[TBL] [Abstract][Full Text] [Related]
15. Unusual susceptibility of a multidrug-resistant yeast strain to peptidic antifungals.
Milewski S; Mignini F; Prasad R; Borowski E
Antimicrob Agents Chemother; 2001 Jan; 45(1):223-8. PubMed ID: 11120970
[TBL] [Abstract][Full Text] [Related]
16. Peptide dendrimers as antifungal agents and carriers for potential antifungal agent-N
Stolarska M; Gucwa K; Urbańczyk-Lipkowska Z; Andruszkiewicz R
J Pept Sci; 2020 Jan; 26(1):e3226. PubMed ID: 31845463
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the inhibition pathway of glucosamine synthase by N3-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid by semiempirical quantum mechanical and molecular mechanics methods.
Tarnowska M; Oldziej S; Liwo A; Grzonka Z; Borowski E
Eur Biophys J; 1992; 21(4):273-80. PubMed ID: 1425480
[TBL] [Abstract][Full Text] [Related]
18. The synthesis and biological activity of lipophilic derivatives of bicine conjugated with N³-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid (FMDP)-an inhibitor of glucosamine-6-phosphate synthase.
Koszel D; Lącka I; Kozłowska-Tylingo K; Andruszkiewicz R
J Enzyme Inhib Med Chem; 2012 Apr; 27(2):167-73. PubMed ID: 21635214
[TBL] [Abstract][Full Text] [Related]
19. Glucosamine-6-phosphate synthase, a novel target for antifungal agents. Molecular modelling studies in drug design.
Wojciechowski M; Milewski S; Mazerski J; Borowski E
Acta Biochim Pol; 2005; 52(3):647-53. PubMed ID: 16082410
[TBL] [Abstract][Full Text] [Related]
20. N3-oxoacyl derivatives of L-2,3-diaminopropanoic acid and their peptides; novel inhibitors of glucosamine-6-phosphate synthase.
Andruszkiewicz R; Jedrzejczak R; Zieniawa T; Wojciechowski M; Borowski E
J Enzyme Inhib; 2000; 15(5):429-41. PubMed ID: 11030083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
